Narciclasine, a novel topoisomerase I inhibitor, exhibited potent anti-cancer activity against cancer cellsMeichen Wang(University of Massachusetts Amherst), Chen Qing(Kunming Medical University)Natural Products and BioprospectingAugust 29, 202310.1007/s13659-023-00392-1Cited by 20SaveCiteExport RISWatch citationsRelated PapersLinalool inhibits 22Rv1 prostate cancer cell proliferation and induces apoptosis|Oncology Letters|2020|38Chronic exposure to the gibberellin derivative GA‑13315 sensitizes breast cancer MCF‑7 cells but not colon cancer HCT116 cells to irinotecan|Oncology Letters|2020|2